No and no intention. To review:
P/E of 1345 *industry average of 24.
Market Capitalization of 3.1b on only Q3 57m revenue
Q3 EPS miss and revenue miss.
Natpara FDA delay with no clarity provided in Q3 CC on January 2015 PDUFA just optimism (which is not a factor in the FDA decision).
Q3 Gattex sales on the VERY BOTTOM end of NPS guidance. A single unit less and they will fall below guidance.
Goldman Sachs downgrade to neutral.
CFO Luke Beshar insider sales 10/27 30.6K shares @ $26.75pps 25% of total shares
10/31 10K shares @ $29pps 10% of total shares
You should take the money and run.
Gattex did miss on growth and badly, not sure what you are addressing here. The Q3 CC was just released and Gattex sales have slowed to almost below guidance. The p/e of NPS is 1345. That is absolutely unsustainable after this Q3 report.
In the event of any delay or CRL, documented communication with the FDA is what is required for increased certainty, which was not available. The officers are always required to be optimistic about the PDUFA, it is their jobs. However, if you see insider sales, particularly around the delay, this is indicative of additional trouble. We did in fact see this with the CFO sales.
Blue dye is an FDA documented inferior product that, if utilized, and resulted in undue suffering, misdiagnosis or wrongful death, absolutely.
No intention of covering. Thesis: Natpara PDUFA in January 2015 will be a CRL if NPS does not pull it first. Gattex sales will regress and guidance will be lowered for 2015. Q4 2014 will miss expectations. Insiders sales will continue.
My short remains, now, highly profitable since PDUFA delay and Q3 EPS and revenue miss. No certainty provided on Natpara delay in CC, this is very bad, and Gattex sales are on the very bottom of the NPS provided guidance with any small issue causing an immediate missed guidance and across the board downgrades. Combine that with 2 insider sales from the CFO in the last 2 weeks.
NPSP missed badly and is -6.3% in after hours in the first 20 minutes. This cognitive dissonance you are so committed to is losing you money.
Correct they are all knockoffs and even say GoPro on them. GoPro has no legal recourse in Chinese courts to stop the pirating. Also, they are not selling well. In fact, that is where the data has been compiled from. China will be a net loss for GoPro just like it was for Google.
GoPro does not equal Apple. You are equating the Hero4 with the iPhone. That is complete lunacy. In addition, the iPhone is assembled at Foxxconn, in China, so it is, technically, a domestic product.
Conversely, the Chinese have had over a year to demonstrate interest in these cameras, via the knockoffs that even say GoPro on them, and have not. Not even close, actually. Why would that change? Also, why would the Chinese government even allow an imported product? The same government the booted Google out.
The Chinese have been pirating Beats headphones and GoPro for some time. So, we have a large amount of data already. The pirated GoPro cameras are not popular in China. Why would the real cameras sell better at, literally, 40x the price?
This PR release is not, actually, a PR release. It's completely speculation based on a tweet from a reporter, who is not affiliated with GoPro. It would be wise to read it.
Except for the motion stabilization hard/software that Sony has and the Hero4 does not. That is a MASSIVE upgrade. The Sony model is also $150 cheaper.
Great drug, too bad Mitsubishi and AUXL make all the profit and Vivus makes so little they won't even disclose the amount.
still_one, poor due diligence. Where do you think the current police footage comes from? These contracts are already awarded and GoPro did not win a single one of them. Far out-priced and unable to be customized for police use.
There is next to no short float because the share supply was cut off. I check everyday. It's all puts. Sorry, no chance of a short squeeze when their are no shorts.